Skip to Content

NEW

A vastly improved search engine helps you find the latest on companies, business leaders, and news more easily.

SIGN IN

Regeneron Pharmaceuticals

The biopharmaceutical company develops and manufactures medicines designed to treat a range of illnesses, including asthma, chronic pain, cancer, and infectious diseases. In the latter category, Regeneron is deeply involved in the pursuit of treatments for COVID-19.

Courtesy of Regeneron

Lists ranking Regeneron Pharmaceuticals

100 Best Companies to Work For - 2021Our 2021 list of the 100 best companies to work fo...READ MOREview in list

100 Fastest-Growing Companies - 2020Collectively, the ranked companies produced a thre...READ MOREview in list

Change the World - 2020As we face unprecedented collective challenges, co...READ MOREview in list

Fortune 500 - 2020This year's Fortune 500 marks the 66th running of ...READ MOREview in list

Latest news for Regeneron Pharmaceuticals

COVID treatments like the experimental antibody therapeutic Trump received are making progress

By

October 7, 2020 10:15 PM UTC

Trump is being treated with a COVID drug that wasn’t one of the questionable therapies he’s previously touted

By

October 2, 2020 11:14 PM UTC

Drug giant Regeneron responds to backlash over cofounder’s ‘All Lives Matter’ graduation speech

By

July 2, 2020 6:58 PM UTC

Will COVID-19 change how Big Pharma does clinical trials?

By

May 15, 2020 10:00 AM UTC

Big pharma’s big chance

By

and

April 3, 2020 10:19 AM UTC

© 2020 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell My Personal Information | Ad Choices
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.
Quotes delayed at least 15 minutes. Market data provided by Interactive Data. ETF and Mutual Fund data provided by Morningstar, Inc. Dow Jones Terms & Conditions: http://www.djindexes.com/mdsidx/html/tandc/indexestandcs.html.
S&P Index data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.